Dyadic International, Inc. Announces Changes to its Board of Directors

International, Inc. Announces Changes to its Board of Directors

Fla - March 14, 2008 - Dyadic International, Inc. (the "Company") today announced

the election of Mr. Wendell H. Adair, Jr., to the Board of Directors (the "Board") of the Company.

Mr. Adair replaces Mr. Richard J. Berman, who has resigned from the

14, 2008, the Executive Committee (the "Executive Committee") of

the Board elected Wendell H. Adair, Jr. as a Class I director for a term

expiring at the Company's 2008 annual stockholders meeting (see the below

regarding the 211 Action (as defined below)) to fill the vacancy arising as a

result of Mr. Berman's resignation. Upon being elected as a director,

Mr. Adair was appointed as a member of the Executive Committee, and the size of

the Executive Committee was fixed at four members. The other members

of the Executive Committee are Messrs. Harry Z. Rosengart (Chairman), Stephen J.

Warner and Wayne Moor. Mr. Adair was also appointed as a member and

chairman of the Board's Audit Committee and Compensation Committee, and as the

Board's lead independent director. There are no arrangements or

understandings between Mr. Adair and any director or other person pursuant to

which Mr. Adair was selected as a director. In addition, there are no

relationships or related transactions between Mr. Adair, the other directors and

the Company of the type required to be disclosed under Item 404(a) of Regulation

H. Adair, Jr. is a member of M&A Development Company LLC, a real estate

development firm. He is a senior lawyer with 35 years of experience

specializing in restructuring and corporate finance. Until April

2006, he held Senior Partner positions at leading U.S. law firms, including

Stroock & Stroock & Lavan LLP from September 1999 to April 2006 and

McDermott, Will & Emery from September 1989 to September 1999. He

is currently a member of the board of directors of Atari, Inc., currently serves

and has previously served on the boards of private companies and has advised

corporate boards with respect to governance, fiduciary duty and financing

10, 2008, Richard J. Berman resigned as a member of the Board and all committees

thereof due to additional time commitments related to his recent appointment as

the Chairman and Chief Executive Officer of Morlex, Inc. Mr. Berman

had been a Class I director of the Company, whose term was scheduled to expire

at the Company's 2008 annual stockholders meeting. The Company's

annual meeting of stockholders in 2008 is currently the subject of litigation in

the Delaware Court of Chancery, as discussed below.

of Chancery of the State of Delaware has scheduled a hearing for April 8, 2008

relating to the petition previously filed by Mark A. Emalfarb, in his capacity

as trustee of the Mark A. Emalfarb Trust, a stockholder of the Company, pursuant

to Section 211 of the General Corporation Law of the State of Delaware (the

Action"). By way of background, as previously disclosed in the

Company's Current Reports on Form 8-K (filed on November 19, 2007, December 28,

2007 and March 4, 2008), Mr. Emalfarb's petition in the 211 Action seeks an

order of the Court directing the Company to call and hold an annual meeting of

its stockholders for the election of directors. The Company does not

oppose a court order directing the Company to call and hold an annual meeting of

stockholders to elect two directors. The parties disagree about the

number of classes of directors that should be elected at an annual meeting and

about the appropriate date for such a meeting, and have recently completed

briefing on cross-motions for judgment on the pleadings with respect to those

issues. The Company intends to vigorously pursue its interests in

connection with the 211 Action, but no assurance can be given as to the timing,

costs to defend or the ultimate outcome of this matter.

14, 2008, the Company filed with the Securities and Exchange Commission a

Current Report on Form 8-K, which includes a copy of this press release as an

NOTICES RE: THIS PRESS RELEASE

information included in this press release may be deemed to be solicitation

material in respect of the election of certain persons who may be nominated for

reelection or to replace certain of the Company's directors whose terms have

expired. If the Company remains subject to the proxy rules of the

Securities and Exchange Commission (the "SEC") at the time any

forms of proxy, consent or authorization are furnished by the Company to

stockholders, such forms of proxy, consent or authorization will be accompanied

by a definitive proxy statement and/or related

materials. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ANY SUCH

PROXY STATEMENT WHEN AND IF IT BECOMES AVAILABLE SINCE IT WILL CONTAIN IMPORTANT

INFORMATION. Investors and stockholders will be able to obtain such

proxy statement/materials, and any other relevant documents, when and if filed

with the SEC free of charge at the SEC's website, located at http://www.sec.gov,

and the Company's stockholders will receive copies of such documents at an

appropriate time from the Company free of charge. The Company and its

directors and executive officers may be deemed to be participants in the

solicitation of proxies from the Company's stockholders in respect of the

election of certain persons who may be nominated for reelection or to replace

certain of the Company's directors whose terms have

expired. Information regarding the directors and executive officers

of the Company is set forth in the Company's Annual Report on Form 10-K for the

fiscal year ended December 31, 2006, which was filed with the SEC on April 2,

2007, and Current Reports on Form 8-K subsequently filed with the SEC on April

25, 2007, June 1, 2007, July 9, 2007, September 24, 2007, October 1, 2007,

October 24, 2007, November 19, 2007 and March 4, 2008. This

communication does not constitute a request for a proxy. THIS

DISCLAIMER SHALL NOT BE CONSTRUED AS AN ADMISSION BY THE COMPANY THAT THIS

COMMUNICATION (OR ANY PORTION OF IT) CONSTITUTES SOLICITATION MATERIAL OR THAT

THIS COMMUNICATION (OR ANY PORTION OF IT) IS BEING FURNISHED TO SECURITY HOLDERS

UNDER CIRCUMSTANCES CALCULATED TO RESULT IN THE PROCUREMENT, WITHHOLDING OR

REVOCATION OF A PROXY OR VOTE ON ANY MATTER.

Dyadic International, Inc.

International, Inc. is a biotechnology company that uses its patented and

proprietary technologies to conduct research and development activities for the

discovery, development, and manufacture of products and enabling solutions to

the bioenergy, industrial enzyme and pharmaceutical industries.

Relations Counsel to Dyadic International, Inc.

Berkman, 310-826-5051